la0c01776_si_001.pdf (1 MB)

DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes

Download (1 MB)
journal contribution
posted on 20.10.2020, 19:09 by Marianna Carone, Silvia Moreno, Michela Cangiotti, Maria Francesca Ottaviani, Peng Wang, Riccardo Carloni, Dietmar Appelhans
Copper (Cu)­(II) ions, mainly an excess amount, play a negative role in the course of several diseases, like cancers, neurodegenerative diseases, and the so-called Wilson disease. On the contrary, Cu­(II) ions are also capable of improving anticancer drug efficiency. For this reason, it is of great interest to study the interacting ability of Cu­(II)–nanodrug and Cu­(II)–nanocarrier complexes with cell membranes for their potential use as nanotherapeutics. In this study, the complex interaction between 1,4,7,10-tetraazacyclododecan-N,N′,N′′,N′′′-tetraacetic acid (DOTA)-functionalized poly­(propyleneimine) (PPI) glycodendrimers and Cu­(II) ions and/or neutral and anionic lipid membrane models using different liposomes is described. These interactions were investigated via dynamic light scattering (DLS), ζ-potential (ZP), electron paramagnetic resonance (EPR), fluorescence anisotropy, and cryogenic transmission electron microscopy (cryo-TEM). Structural and dynamic information about the PPI glycodendrimer and its Cu­(II) complexes toward liposomes was obtained via EPR. At the binding site Cu–N2O2 coordination prevails, while at the external interface, this coordination partially weakens due to competitive dendrimer–liposome interactions, with only small liposome structural perturbation. Fluorescence anisotropy was used to evaluate the membrane fluidity of both the hydrophobic and hydrophilic parts of the lipid bilayer, while DLS and ZP allowed us to determine the distribution profile of the nanoparticle (PPI glycodendrimer and liposomes) size and surface charge, respectively. From this multitechnique approach, it is deduced that DOTA-PPI glycodendrimers selectively extract Cu­(II) ions from the bioenvironment, while these complexes interact with the liposome surface, preferentially with even more negatively charged liposomes. However, these complexes are not able to cross the cell membrane model and poorly perturb the membrane structure, showing their potential for biomedical use.

History